Variant report
Variant | nsv1034140 |
---|---|
Chromosome Location | chr9:11196016-11245402 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000054392 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs901986 | chr9:11196016-11196017 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs10756203 | chr9:11196081-11196082 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs543911676 | chr9:11196114-11196115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7043445 | chr9:11196141-11196142 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs181310231 | chr9:11196147-11196148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537935057 | chr9:11196159-11196160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548268386 | chr9:11196174-11196175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11999647 | chr9:11196189-11196190 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs145248202 | chr9:11196236-11196237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554374764 | chr9:11196258-11196259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570012823 | chr9:11196273-11196274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577452913 | chr9:11196334-11196335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539784886 | chr9:11196351-11196352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542554303 | chr9:11196382-11196383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12156565 | chr9:11196389-11196390 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs541830379 | chr9:11196413-11196414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555543803 | chr9:11196418-11196419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572524220 | chr9:11196431-11196432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10809383 | chr9:11196439-11196440 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs560326872 | chr9:11196463-11196464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186266468 | chr9:11196494-11196495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12342410 | chr9:11196536-11196537 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs117991396 | chr9:11196556-11196557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562772460 | chr9:11196570-11196571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371654770 | chr9:11196582-11196583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564461619 | chr9:11196596-11196597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192072984 | chr9:11196623-11196624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145032652 | chr9:11196624-11196625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs527418837 | chr9:11196635-11196636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531714662 | chr9:11196649-11196650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549933936 | chr9:11196656-11196657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372558945 | chr9:11196659-11196660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539649194 | chr9:11196684-11196685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112497673 | chr9:11196688-11196689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556400309 | chr9:11196692-11196693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374829539 | chr9:11196710-11196711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2130121 | chr9:11196733-11196734 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs149079192 | chr9:11196736-11196737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538221416 | chr9:11196745-11196746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572432797 | chr9:11196747-11196748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371495552 | chr9:11196748-11196749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541551695 | chr9:11196756-11196757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6474639 | chr9:11196759-11196760 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs370094420 | chr9:11196777-11196778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs151053460 | chr9:11196798-11196799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562746716 | chr9:11196804-11196805 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs531667415 | chr9:11196827-11196828 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541448374 | chr9:11196841-11196842 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181692868 | chr9:11196845-11196846 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs6474640 | chr9:11196847-11196848 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11195200-11196200 | Enhancers | Brain Germinal Matrix | brain |
2 | chr9:11196000-11196800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr9:11196800-11197200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr9:11197200-11203000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr9:11199000-11199800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr9:11199200-11199800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr9:11199200-11199800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr9:11199200-11200400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr9:11199400-11199800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr9:11199600-11200400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr9:11207600-11207800 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
12 | chr9:11233800-11235200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr9:11234600-11235800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |